Backed by billionaire Mike Platt, Engitix scores another deal with Takeda to go after IBD

Engitix is on a roll.

The British biotech backed by billionaire hedge fund manager Mike Platt secured an expansion on its earlier Takeda deal, it …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Backed by bil­lion­aire Mike Platt, En­gi­tix scores an­oth­er deal with Take­da to go af­ter IBD